Simulations Plus Inc (SLP) - Financial and Strategic SWOT Analysis Review

November 2021 | 49 pages | ID: S7C3F67C6AEEN
GlobalData

Abstracts

Simulations Plus Inc (SLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides preclinical and clinical pharmacometric consulting services to help its customers with regulatory submissions. Simulations Plus’ pharmaceutical and chemistry software is licensed to agrochemical, biotechnology, pharmaceutical and food industries, and regulatory agencies worldwide. The company also offers training workshops and provides consulting services. It distributes products and offers services throughout the world. Simulations Plus is headquartered in Lancaster, California, the US.

Simulations Plus Inc Key Recent Developments

Oct 26,2021: Simulations Plus and the University of Connecticut awarded new FDA contract to accelerate the development of long-acting injectable products
Oct 25,2021: Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results
Aug 19,2021: Simulations Plus reports continued success in second phase of AIDD collaboration with large pharmaceutical company
Jun 17,2021: Simulations Plus releases IPFsym version 1A, state-of-the-art quantitative systems pharmacology (QSP) software for idiopathic pulmonary fibrosis (IPF)
May 27,2021: Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Simulations Plus Inc - Key Facts
Simulations Plus Inc - Key Employees
Simulations Plus Inc - Key Employee Biographies
Simulations Plus Inc - Major Products and Services
Simulations Plus Inc - History
Simulations Plus Inc - Company Statement
Simulations Plus Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Simulations Plus Inc - Business Description
Business Segment: Cognigen Corporation
Overview
Performance
Business Segment: DILIsym Services Inc
Overview
Performance
Business Segment: Lixoft
Overview
Performance
Business Segment: Simulations Plus Inc
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: The US
Performance
Simulations Plus Inc - Corporate Strategy
Simulations Plus Inc - SWOT Analysis
SWOT Analysis - Overview
Simulations Plus Inc - Strengths
Simulations Plus Inc - Weaknesses
Simulations Plus Inc - Opportunities
Simulations Plus Inc - Threats
Simulations Plus Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Simulations Plus Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Simulations Plus Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Simulations Plus Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 26, 2021: Simulations Plus and the University of Connecticut awarded new FDA contract to accelerate the development of long-acting injectable products
Oct 25, 2021: Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results
Aug 19, 2021: Simulations Plus reports continued success in second phase of AIDD collaboration with large pharmaceutical company
Jun 17, 2021: Simulations Plus releases IPFsym version 1A, state-of-the-art quantitative systems pharmacology (QSP) software for idiopathic pulmonary fibrosis (IPF)
May 27, 2021: Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference
May 13, 2021: Simulations Plus to Present at 16th Annual Needham Virtual Technology & Media Conference
Apr 27, 2021: Simulations Plus releases ADMET Predictor (X.2)
Apr 20, 2021: U.S. FDA renews licenses of DILIsym software
Apr 12, 2021: Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
Apr 07, 2021: Simulations Plus reports successful results from AIDD collaboration with large pharmaceutical company

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Simulations Plus Inc, Key Facts
Simulations Plus Inc, Key Employees
Simulations Plus Inc, Key Employee Biographies
Simulations Plus Inc, Major Products and Services
Simulations Plus Inc, History
Simulations Plus Inc, Other Locations
Simulations Plus Inc, Subsidiaries
Simulations Plus Inc, Key Competitors
Simulations Plus Inc, Ratios based on current share price
Simulations Plus Inc, Annual Ratios
Simulations Plus Inc, Annual Ratios (Cont...1)
Simulations Plus Inc, Annual Ratios (Cont...2)
Simulations Plus Inc, Interim Ratios
Simulations Plus Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Simulations Plus Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Simulations Plus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Simulations Plus Inc, Performance Chart (2017 - 2021)
Simulations Plus Inc, Ratio Charts
Simulations Plus Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Simulations Plus Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021